Michael Cabanero

2.9k total citations
52 papers, 1.7k citations indexed

About

Michael Cabanero is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Michael Cabanero has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Michael Cabanero's work include Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Michael Cabanero is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Michael Cabanero collaborates with scholars based in Canada, United States and United Kingdom. Michael Cabanero's co-authors include Ming‐Sound Tsao, Francis J. McMahon, Sevilla D. Detera‐Wadleigh, Alexander Georgi, Rami Abou Jamra, Winston Corona, John Hardy, Markus M. Nöthen, Thomas G. Schulze and Brygida Klemens and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael Cabanero

46 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Cabanero Canada 21 677 514 504 342 314 52 1.7k
Yohei Mineharu Japan 29 281 0.4× 405 0.8× 507 1.0× 180 0.5× 269 0.9× 128 2.4k
Roohi Ismail‐Khan United States 23 1.1k 1.6× 702 1.4× 898 1.8× 332 1.0× 212 0.7× 60 2.4k
Noah Berkowitz United States 18 466 0.7× 386 0.8× 452 0.9× 101 0.3× 254 0.8× 41 1.8k
Veerle Melotte Netherlands 26 573 0.8× 568 1.1× 1.6k 3.2× 570 1.7× 166 0.5× 53 2.4k
Andreas F. Hottinger Switzerland 27 636 0.9× 596 1.2× 595 1.2× 258 0.8× 63 0.2× 117 2.7k
Amal Melhem‐Bertrandt United States 18 901 1.3× 376 0.7× 392 0.8× 217 0.6× 138 0.4× 43 2.0k
Vei Mah United States 20 507 0.7× 390 0.8× 927 1.8× 236 0.7× 250 0.8× 38 1.7k
Oliver Heese Germany 23 467 0.7× 537 1.0× 1.0k 2.0× 640 1.9× 131 0.4× 63 3.0k
Christine Haberler Austria 30 237 0.4× 348 0.7× 1.2k 2.4× 332 1.0× 79 0.3× 98 2.6k
Kim M. Smits Netherlands 22 324 0.5× 497 1.0× 1.1k 2.1× 430 1.3× 97 0.3× 37 1.7k

Countries citing papers authored by Michael Cabanero

Since Specialization
Citations

This map shows the geographic impact of Michael Cabanero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cabanero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cabanero more than expected).

Fields of papers citing papers by Michael Cabanero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cabanero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cabanero. The network helps show where Michael Cabanero may publish in the future.

Co-authorship network of co-authors of Michael Cabanero

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cabanero. A scholar is included among the top collaborators of Michael Cabanero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cabanero. Michael Cabanero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gregor, Alexander, Hiroyuki Ogawa, T. Koga, et al.. (2024). Feasibility of computed tomography-derived surgical margin assessment in an ex vivo sublobar lung resection model. Interdisciplinary CardioVascular and Thoracic Surgery. 40(1).
2.
Khan, Sam, Thomas K. Waddell, Kazuhiro Yasufuku, et al.. (2024). ctDNA-Lung-DETECT: ctDNA outcomes for resected early stage non-small cell lung cancers at 12 months.. Journal of Clinical Oncology. 42(16_suppl). 8018–8018. 2 indexed citations
3.
Shapera, Shane, et al.. (2023). An unusual case of interstitial lung disease: Revisiting peribronchiolar metaplasia interstitial lung disease (PBM‐ILD). SHILAP Revista de lepidopterología. 11(2). e01081–e01081. 1 indexed citations
4.
Wu, Licun, Zhihong Yun, Trevor D. McKee, et al.. (2021). Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma. Communications Biology. 4(1). 914–914. 8 indexed citations
5.
Hwang, David, Jessica Weiss, Jeffrey Tanguay, et al.. (2021). Prevalence and Heterogeneity of PD-L1 Expression by 22C3 Assay in Routine Population-Based and Reflexive Clinical Testing in Lung Cancer. Journal of Thoracic Oncology. 16(9). 1490–1500. 30 indexed citations
6.
Tong, Jiefei, Jonathan R. Krieger, Paul Taylor, et al.. (2020). Cancer proteome and metabolite changes linked to SHMT2. PLoS ONE. 15(9). e0237981–e0237981. 15 indexed citations
7.
Xia, Daniel, Alberto J. León, Michael Cabanero, et al.. (2020). Minimalist approaches to cancer tissue-of-origin classification by DNA methylation. Modern Pathology. 33(10). 1874–1888. 22 indexed citations
8.
Schmid, Sabine, Erin Stewart, Sebastião N. Martins-Filho, et al.. (2020). Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib. Clinical Lung Cancer. 21(5). e488–e492. 5 indexed citations
9.
Fares, Aline Fusco, Benjamin H. Lok, Tong Zhang, et al.. (2020). ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two cases. Lung Cancer. 146. 350–354. 14 indexed citations
10.
Shi, Ruoshi, Nikolina Radulovich, Christine Ng, et al.. (2019). Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(5). 1162–1174. 204 indexed citations
11.
Pal, Prodipto, Aline Fusco Fares, Erin Stewart, et al.. (2019). MA18.07 Identification of Neuroendocrine Transformation in Anaplastic Lymphoma Kinase Rearranged (ALK+) Tumors After Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology. 14(10). S323–S324.
12.
Perrot, Marc de, Licun Wu, Michael Cabanero, et al.. (2019). Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma. Journal of Thoracic and Cardiovascular Surgery. 159(5). 2082–2091.e1. 20 indexed citations
13.
Cabanero, Michael, Martin Hyrcza, Marcus O. Butler, et al.. (2019). Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarray. Clinical and Translational Radiation Oncology. 17. 32–39. 13 indexed citations
14.
Shi, Ruoshi, Ming Li, Vibha Raghavan, et al.. (2018). Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA -Mutant Lung Squamous Cell Carcinoma. Clinical Cancer Research. 24(23). 5990–6000. 20 indexed citations
15.
Cabanero, Michael, Mor Moskovitz, Jonathan M. Weiss, et al.. (2018). P3.03-29 The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S921–S921. 1 indexed citations
16.
Ly, Dalam, et al.. (2018). P1.04-05 Elucidating the Role of Leukocyte-Associated Immunoglobin-Like Receptor 2 (LAIR2) in Lung Cancer Development. Journal of Thoracic Oncology. 13(10). S526–S527.
17.
Ly, Dalam, Chang‐Qi Zhu, Michael Cabanero, Ming‐Sound Tsao, & Li Zhang. (2017). Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients. Cancer Immunology Research. 5(9). 821–829. 12 indexed citations
18.
Cabanero, Michael, Randeep Sangha, Brandon S. Sheffield, et al.. (2017). Management of Egfr-Mutated Non-Small-Cell Lung Cancer: Practical Implications from a Clinical and Pathology Perspective. Current Oncology. 24(2). 111–119. 21 indexed citations
19.
Kim, Bo Ram, Michael Cabanero, Dennis Wang, et al.. (2016). SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis. PLoS Biology. 14(11). e1002581–e1002581. 38 indexed citations
20.
Baum, Amber E., Nirmala Akula, Michael Cabanero, et al.. (2007). A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Molecular Psychiatry. 13(2). 197–207. 474 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yohei Mineharu Breakdown of academic impact, for papers by Roohi Ismail‐Khan Breakdown of academic impact, for papers by Noah Berkowitz Breakdown of academic impact, for papers by Veerle Melotte Breakdown of academic impact, for papers by Andreas F. Hottinger Breakdown of academic impact, for papers by Amal Melhem‐Bertrandt Breakdown of academic impact, for papers by Vei Mah Breakdown of academic impact, for papers by Oliver Heese Breakdown of academic impact, for papers by Christine Haberler Breakdown of academic impact, for papers by Kim M. Smits
Rankless by CCL
2026